Magnetic resonance spectroscopy for evaluation of suspected brain tumor.
D054598:Blue Cross Blue Shield Insurance Plans; D001932:Brain Neoplasms / Q000175:diagnosis*; D018795:Device Approval; D017277:Drug Approval; D019317:Evidence-Based Medicine; D006801:Humans; D019458:Insurance Coverage; D009682:Magnetic Resonance Spectroscopy; D017063:Outcome Assessment, Health Care; D011522:Protons; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D011522:Protons